28103941|t|Involvement of the endocannabinoid system in the physiological response to transient common carotid artery occlusion and reperfusion
28103941|a|The transient global cerebral hypoperfusion / reperfusion achieved by induction of Bilateral Common Carotid Artery Occlusion followed by Reperfusion (BCCAO / R) may trigger a physiological response in an attempt to preserve tissue and function integrity. There are several candidate molecules among which the endocannabinoid system (ECS) and/or peroxisome-proliferator activated receptor-alpha (PPAR-alpha) may play a role in modulating oxidative stress and inflammation. The aims of the present study are to evaluate whether the ECS, the enzyme cyclooxygenase-2 (COX-2) and PPAR-alpha are involved during BCCAO / R in rat brain, and to identify possible markers of the ongoing BCCAO / R - induced challenge in plasma. Adult Wistar rats underwent BCCAO / R with 30 min hypoperfusion followed by 60 min reperfusion. The frontal and temporal - occipital cortices and plasma were analyzed by high performance liquid chromatography-mass spectrometry (HPLC-MS) to determine concentrations of endocannabinoids (eCBs) and related molecules behaving as ligands of PPAR-alpha, and of oxidative-stress markers such as lipoperoxides, while Western Blot and immunohistochemistry were used to study protein expression of cannabinoid receptors, COX-2 and PPAR-alpha. Unpaired Student's t-test was used to evaluate statistical differences between groups. The acute BCCAO / R procedure is followed by increased brain tissue levels of the eCBs 2-arachidonoylglycerol and anandamide, palmitoylethanolamide, an avid ligand of PPAR-alpha, lipoperoxides, type 1 (CB1) and type 2 (CB2) cannabinoid receptors, and COX-2, and decreased brain tissue concentrations of docosahexaenoic acid (DHA), one of the major targets of lipid peroxidation. In plasma, increased levels of anandamide and lipoperoxides were observed. The BCCAO / R stimulated early molecular changes that can be easily traced in brain tissue and plasma, and that are indicative of the tissue physiological response to the reperfusion - induced oxidative stress and inflammation. The observed variations suggest that the positive modulation of the ECS and the increase of proinflammatory substances are directly correlated events. Increase of plasmatic levels of anandamide and lipoperoxides further suggests that dysregulation of these molecules may be taken as an indicator of an ongoing hypoperfusion / reperfusion challenge.
28103941	19	41	endocannabinoid system	T044	C3156138
28103941	49	71	physiological response	T039	C0542478
28103941	92	116	carotid artery occlusion	T047	C0265101
28103941	121	132	reperfusion	T038	C0684253
28103941	147	176	global cerebral hypoperfusion	T047	C1695782
28103941	179	190	reperfusion	T038	C0684253
28103941	216	257	Bilateral Common Carotid Artery Occlusion	T046	C1386627
28103941	270	281	Reperfusion	T038	C0684253
28103941	283	288	BCCAO	T046	C1386627
28103941	291	292	R	T038	C0684253
28103941	308	330	physiological response	T039	C0542478
28103941	348	356	preserve	T052	C0024501
28103941	357	376	tissue and function	T042	C1254358
28103941	377	386	integrity	T080	C1947912
28103941	416	425	molecules	T167	C0567416
28103941	442	464	endocannabinoid system	T044	C3156138
28103941	466	469	ECS	T044	C3156138
28103941	478	526	peroxisome-proliferator activated receptor-alpha	T116,T192	C0166415
28103941	528	538	PPAR-alpha	T116,T192	C0166415
28103941	559	569	modulating	T082	C0443264
28103941	570	586	oxidative stress	T049	C0242606
28103941	591	603	inflammation	T046	C0021368
28103941	609	613	aims	T078	C1947946
28103941	629	634	study	T062	C0008972
28103941	642	650	evaluate	T058	C0220825
28103941	663	666	ECS	T044	C3156138
28103941	672	678	enzyme	T116,T126	C0014442
28103941	679	695	cyclooxygenase-2	T116,T126	C0387583
28103941	697	702	COX-2	T116,T126	C0387583
28103941	708	718	PPAR-alpha	T116,T192	C0166415
28103941	739	744	BCCAO	T046	C1386627
28103941	747	748	R	T038	C0684253
28103941	752	761	rat brain	T023	C1882598
28103941	788	795	markers	T201	C0005516
28103941	811	816	BCCAO	T046	C1386627
28103941	819	820	R	T038	C0684253
28103941	823	830	induced	T169	C0205263
28103941	844	850	plasma	T031	C0032105
28103941	858	869	Wistar rats	T015	C0034716
28103941	880	885	BCCAO	T046	C1386627
28103941	888	889	R	T038	C0684253
28103941	902	915	hypoperfusion	T046	C0442856
28103941	935	946	reperfusion	T038	C0684253
28103941	952	959	frontal	T023	C0016733
28103941	964	972	temporal	T023	C0039485
28103941	975	993	occipital cortices	T023	C3811911
28103941	998	1004	plasma	T031	C0032105
28103941	1010	1018	analyzed	T062	C0936012
28103941	1022	1078	high performance liquid chromatography-mass spectrometry	T059	C3641325
28103941	1080	1087	HPLC-MS	T059	C3641325
28103941	1102	1116	concentrations	T081	C1446561
28103941	1120	1136	endocannabinoids	T109,T123	C1172779
28103941	1138	1142	eCBs	T109,T123	C1172779
28103941	1156	1165	molecules	T167	C0567416
28103941	1178	1185	ligands	T103	C0023688
28103941	1189	1199	PPAR-alpha	T116,T192	C0166415
28103941	1208	1224	oxidative-stress	T049	C0242606
28103941	1225	1232	markers	T201	C0005516
28103941	1241	1254	lipoperoxides	T109	C0023776
28103941	1262	1274	Western Blot	T059	C0949466
28103941	1279	1299	immunohistochemistry	T060	C0021044
28103941	1313	1318	study	T062	C0008972
28103941	1319	1337	protein expression	T045	C1171362
28103941	1341	1362	cannabinoid receptors	T116,T192	C0054594
28103941	1364	1369	COX-2	T116,T126	C0387583
28103941	1374	1384	PPAR-alpha	T116,T192	C0166415
28103941	1386	1411	Unpaired Student's t-test	T170	C1710574
28103941	1424	1432	evaluate	T058	C0220825
28103941	1433	1444	statistical	T081	C2828391
28103941	1445	1456	differences	T080	C1705242
28103941	1465	1471	groups	T078	C0441833
28103941	1477	1482	acute	T079	C0205178
28103941	1483	1488	BCCAO	T046	C1386627
28103941	1491	1492	R	T038	C0684253
28103941	1528	1540	brain tissue	T023	C0459385
28103941	1555	1559	eCBs	T109,T123	C1172779
28103941	1560	1582	2-arachidonoylglycerol	T109,T121	C0299477
28103941	1587	1597	anandamide	T109,T123	C0211726
28103941	1599	1620	palmitoylethanolamide	T109,T121	C0069964
28103941	1630	1636	ligand	T103	C0023688
28103941	1640	1650	PPAR-alpha	T116,T192	C0166415
28103941	1652	1665	lipoperoxides	T109	C0023776
28103941	1667	1673	type 1	T116,T192	C0378126
28103941	1675	1678	CB1	T116,T192	C0378126
28103941	1684	1690	type 2	T116,T192	C0208757
28103941	1692	1695	CB2	T116,T192	C0208757
28103941	1697	1718	cannabinoid receptors	T116,T192	C0054594
28103941	1724	1729	COX-2	T116,T126	C0387583
28103941	1745	1757	brain tissue	T023	C0459385
28103941	1758	1772	concentrations	T081	C1446561
28103941	1776	1796	docosahexaenoic acid	T109,T121,T123	C0012968
28103941	1798	1801	DHA	T109,T121,T123	C0012968
28103941	1821	1828	targets	T169	C1521840
28103941	1832	1850	lipid peroxidation	T044	C0023775
28103941	1855	1861	plasma	T031	C0032105
28103941	1883	1893	anandamide	T109,T123	C0211726
28103941	1898	1911	lipoperoxides	T109	C0023776
28103941	1917	1925	observed	T169	C1441672
28103941	1931	1936	BCCAO	T046	C1386627
28103941	1939	1940	R	T038	C0684253
28103941	1941	1951	stimulated	T070	C1948023
28103941	1958	1967	molecular	T080	C1521991
28103941	1968	1975	changes	T169	C0392747
28103941	2005	2017	brain tissue	T023	C0459385
28103941	2022	2028	plasma	T031	C0032105
28103941	2043	2053	indicative	T078	C3146298
28103941	2061	2067	tissue	T024	C0040300
28103941	2068	2090	physiological response	T039	C0542478
28103941	2098	2109	reperfusion	T038	C0684253
28103941	2112	2119	induced	T169	C0205263
28103941	2120	2136	oxidative stress	T049	C0242606
28103941	2141	2153	inflammation	T046	C0021368
28103941	2159	2167	observed	T169	C1441672
28103941	2168	2178	variations	T080	C0205419
28103941	2205	2215	modulation	T082	C0443264
28103941	2223	2226	ECS	T044	C3156138
28103941	2247	2262	proinflammatory	T123	C0574031
28103941	2318	2327	plasmatic	T031	C0032105
28103941	2338	2348	anandamide	T109,T123	C0211726
28103941	2353	2366	lipoperoxides	T109	C0023776
28103941	2389	2402	dysregulation	T038	C1327622
28103941	2412	2421	molecules	T167	C0567416
28103941	2441	2450	indicator	T169	C1522602
28103941	2465	2478	hypoperfusion	T046	C0442856
28103941	2481	2492	reperfusion	T038	C0684253